ConductScience.org, home

Paper356267

Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi.

Marr JJ and 2 others. Science, 1978. Cited by 99 papers, by iCite.

Cite this record

ConductScience Library. Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi. Papers, record 356267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356267

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi.
PubMed
Journal
Science
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
99
iCite
Relative citation ratio, by iCite
3.74
iCite
Revised in PubMed
2019-06-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marr JJJ J
2Berens RLR L
3Nelson DJD J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AllopurinolMajor topic
Pyrimidine NucleotidesMajor topic
Trypanocidal AgentsMajor topic
Trypanosoma cruziMajor topic
Adenine
Animals
Ribonucleotides

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.

PMIDTitleJournalYearIn PapersSource
37762080From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease.Int J Mol Sci2023https://conductscience.org/library/papers/37762080PubMed
35957576Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.Parasitology2022https://conductscience.org/library/papers/35957576PubMed
33833592Review on Experimental Treatment Strategies Against Trypanosoma cruzi.J Exp Pharmacol2021https://conductscience.org/library/papers/33833592PubMed
30962342Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30962342PubMed
29016289Experimental and Clinical Treatment of Chagas Disease: A Review.Am J Trop Med Hyg2017https://conductscience.org/library/papers/29016289PubMed
27729503Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols.SLAS Discov2017https://conductscience.org/library/papers/27729503PubMed
24596669Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity.Int J Parasitol Drugs Drug Resist2014https://conductscience.org/library/papers/24596669PubMed
24277328Pyrazolopyrimidine metabolism in parasitic protozoa.Pharm Res1984https://conductscience.org/library/papers/24277328PubMed
18369465Plasmodium-induced inflammation by uric acid.PLoS Pathog2008https://conductscience.org/library/papers/18369465PubMed
16127040Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16127040PubMed
8517715Effects of probenecid on the pharmacokinetics of allopurinol riboside.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8517715PubMed
8415556Molecular biology studies of tubercidin resistance in Trypanosoma cruzi.Parasitol Res1993https://conductscience.org/library/papers/8415556PubMed
7896566A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase.Histochem J1994https://conductscience.org/library/papers/7896566PubMed
6817705Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6817705PubMed
6767543Tropical diseases encountered in Canada: 1. Chagas' disease.Can Med Assoc J1980https://conductscience.org/library/papers/6767543PubMed
6712205Biological action of inosine analogs in Leishmania and Trypanosoma spp.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6712205PubMed
6605408Purine salvage networks in Giardia lamblia.J Exp Med1983https://conductscience.org/library/papers/6605408PubMed
6573672Pyrimidine metabolism in Tritrichomonas foetus.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6573672PubMed
6273876Purine metabolism in the protozoan parasite Eimeria tenella.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6273876PubMed
3973534Pyrimidine salvage in Giardia lamblia.J Exp Med1985https://conductscience.org/library/papers/3973534PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/356267

GET https://conductscience.org/api/papers/v1/356267/cited_by?page=2